SG11201404941WA - Use of a pyrazole derivative in the treatment of acute exacerbations of chronic obstructive pulmonary disease - Google Patents
Use of a pyrazole derivative in the treatment of acute exacerbations of chronic obstructive pulmonary diseaseInfo
- Publication number
- SG11201404941WA SG11201404941WA SG11201404941WA SG11201404941WA SG11201404941WA SG 11201404941W A SG11201404941W A SG 11201404941WA SG 11201404941W A SG11201404941W A SG 11201404941WA SG 11201404941W A SG11201404941W A SG 11201404941WA SG 11201404941W A SG11201404941W A SG 11201404941WA
- Authority
- SG
- Singapore
- Prior art keywords
- treatment
- pulmonary disease
- chronic obstructive
- obstructive pulmonary
- pyrazole derivative
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/38—Nitrogen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261613187P | 2012-03-20 | 2012-03-20 | |
| PCT/EP2013/055730 WO2013139809A1 (en) | 2012-03-20 | 2013-03-19 | Use of a pyrazole derivative in the treatment of acute exacerbations of chronic obstructive pulmonary disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201404941WA true SG11201404941WA (en) | 2014-10-30 |
Family
ID=47901996
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201404941WA SG11201404941WA (en) | 2012-03-20 | 2013-03-19 | Use of a pyrazole derivative in the treatment of acute exacerbations of chronic obstructive pulmonary disease |
Country Status (30)
| Country | Link |
|---|---|
| US (2) | US9339491B2 (zh) |
| EP (1) | EP2827860B1 (zh) |
| JP (1) | JP6091593B2 (zh) |
| KR (1) | KR101793777B1 (zh) |
| CN (1) | CN104203234B (zh) |
| AU (1) | AU2013237503B2 (zh) |
| BR (1) | BR112014023107B1 (zh) |
| CA (1) | CA2866108C (zh) |
| CL (1) | CL2014002471A1 (zh) |
| CY (1) | CY1118327T1 (zh) |
| DK (1) | DK2827860T3 (zh) |
| ES (1) | ES2605942T3 (zh) |
| HK (1) | HK1200352A1 (zh) |
| HR (1) | HRP20161514T1 (zh) |
| HU (1) | HUE032004T2 (zh) |
| IL (1) | IL234537A (zh) |
| LT (1) | LT2827860T (zh) |
| MA (1) | MA37455B1 (zh) |
| MX (1) | MX351996B (zh) |
| NZ (1) | NZ628392A (zh) |
| PH (1) | PH12014502107B1 (zh) |
| PL (1) | PL2827860T3 (zh) |
| PT (1) | PT2827860T (zh) |
| RU (1) | RU2625762C2 (zh) |
| SG (1) | SG11201404941WA (zh) |
| SI (1) | SI2827860T1 (zh) |
| TN (1) | TN2014000350A1 (zh) |
| TW (1) | TWI583381B (zh) |
| WO (1) | WO2013139809A1 (zh) |
| ZA (1) | ZA201405871B (zh) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2600822C1 (ru) * | 2015-09-03 | 2016-10-27 | ФЕДЕРАЛЬНОЕ ГОСУДАРСТВЕННОЕ БЮДЖЕТНОЕ УЧРЕЖДЕНИЕ "РОССИЙСКИЙ НАУЧНЫЙ ЦЕНТР РАДИОЛОГИИ И ХИРУРГИЧЕСКИХ ТЕХНОЛОГИЙ" МИНИСТЕРСТВА ЗДРАВООХРАНЕНИЯ РОССИЙСКОЙ ФЕДЕРАЦИИ (ФГБУ "РНЦРХТ" Минздрава России) | Способ лечения хронического обструктивного бронхита |
| RU2600833C1 (ru) * | 2015-09-03 | 2016-10-27 | ФЕДЕРАЛЬНОЕ ГОСУДАРСТВЕННОЕ БЮДЖЕТНОЕ УЧРЕЖДЕНИЕ "РОССИЙСКИЙ НАУЧНЫЙ ЦЕНТР РАДИОЛОГИИ И ХИРУРГИЧЕСКИХ ТЕХНОЛОГИЙ" МИНИСТЕРСТВА ЗДРАВООХРАНЕНИЯ РОССИЙСКОЙ ФЕДЕРАЦИИ (ФГБУ "РНЦРХТ" Минздрава России) | Способ лечения хронической обструктивной болезни легких |
| JP6741773B2 (ja) * | 2016-03-08 | 2020-08-19 | メレオ バイオファーマ １ リミテッド | 炎症状態の急性増悪の治療のための投与レジメン |
| CA3016488C (en) * | 2016-03-08 | 2023-04-11 | Mereo Biopharma 1 Limited | Dosage regimen for the treatment of acute exacerbations of chronic obstructive pulmonary disease |
| US10331542B2 (en) * | 2016-06-23 | 2019-06-25 | International Business Machines Corporation | System and method for detecting and alerting unexpected behavior of software applications |
| GB201612238D0 (en) | 2016-07-14 | 2016-08-31 | Mereo Biopharma 1 Ltd | Method for producing a polymorphic form of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-Yl]-n-cyclopropyl-4-methylbenzamide |
| GB201612240D0 (en) * | 2016-07-14 | 2016-08-31 | Mereo Biopharma 1 Ltd | Method for producing a polymorphic form of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide |
| HRP20221196T1 (hr) | 2017-10-05 | 2022-12-09 | Fulcrum Therapeutics, Inc. | Inhibitori p38 kinaze smanjuju ekspresiju dux4 i nizvodnih gena u cilju liječenja fshd |
| US10342786B2 (en) | 2017-10-05 | 2019-07-09 | Fulcrum Therapeutics, Inc. | P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD |
| HUE054266T2 (hu) | 2017-12-11 | 2021-08-30 | Mereo Biopharma 1 Ltd | 3-[5-amino-4-(3-cianobenzoil)-pirazol-1-il]-N-ciklopropil-4-metilbenzamid alkalmazása krónikus obstruktív tüdõbetegség akut megjelenésének megelõzésében |
| JP7280627B2 (ja) | 2017-12-11 | 2023-05-24 | メレオ バイオファーマ １ リミテッド | 慢性閉塞性肺疾患の急性増悪の処置における３－［５－アミノ－４－（３－シアノベンゾイル）－ピラゾール－１－イル］－ｎ－シクロプロピル－４－メチルベンズアミドの使用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4838121B2 (ja) * | 2003-06-26 | 2011-12-14 | ノバルティス アーゲー | ５員ヘテロ環を基礎とするｐ３８キナーゼ阻害剤 |
| GB0603684D0 (en) * | 2006-02-23 | 2006-04-05 | Novartis Ag | Organic compounds |
-
2013
- 2013-03-19 LT LTEP13710851.0T patent/LT2827860T/lt unknown
- 2013-03-19 TW TW102109739A patent/TWI583381B/zh active
- 2013-03-19 PT PT137108510T patent/PT2827860T/pt unknown
- 2013-03-19 PL PL13710851T patent/PL2827860T3/pl unknown
- 2013-03-19 DK DK13710851.0T patent/DK2827860T3/en active
- 2013-03-19 EP EP13710851.0A patent/EP2827860B1/en active Active
- 2013-03-19 SG SG11201404941WA patent/SG11201404941WA/en unknown
- 2013-03-19 RU RU2014141893A patent/RU2625762C2/ru active
- 2013-03-19 US US14/386,174 patent/US9339491B2/en active Active
- 2013-03-19 MA MA37455A patent/MA37455B1/fr unknown
- 2013-03-19 CN CN201380015703.5A patent/CN104203234B/zh active Active
- 2013-03-19 KR KR1020147025904A patent/KR101793777B1/ko active IP Right Grant
- 2013-03-19 JP JP2015500892A patent/JP6091593B2/ja active Active
- 2013-03-19 NZ NZ628392A patent/NZ628392A/en unknown
- 2013-03-19 ES ES13710851.0T patent/ES2605942T3/es active Active
- 2013-03-19 SI SI201330397A patent/SI2827860T1/sl unknown
- 2013-03-19 CA CA2866108A patent/CA2866108C/en active Active
- 2013-03-19 BR BR112014023107-9A patent/BR112014023107B1/pt active IP Right Grant
- 2013-03-19 WO PCT/EP2013/055730 patent/WO2013139809A1/en active Application Filing
- 2013-03-19 AU AU2013237503A patent/AU2013237503B2/en active Active
- 2013-03-19 MX MX2014011291A patent/MX351996B/es active IP Right Grant
- 2013-03-19 HU HUE13710851A patent/HUE032004T2/en unknown
-
2014
- 2014-08-11 TN TNP2014000350A patent/TN2014000350A1/fr unknown
- 2014-08-11 ZA ZA2014/05871A patent/ZA201405871B/en unknown
- 2014-09-08 IL IL234537A patent/IL234537A/en active IP Right Grant
- 2014-09-17 CL CL2014002471A patent/CL2014002471A1/es unknown
- 2014-09-22 PH PH12014502107A patent/PH12014502107B1/en unknown
-
2015
- 2015-01-29 HK HK15101000.9A patent/HK1200352A1/zh unknown
-
2016
- 2016-04-29 US US15/143,356 patent/US20160243081A1/en not_active Abandoned
- 2016-11-16 HR HRP20161514TT patent/HRP20161514T1/hr unknown
- 2016-11-18 CY CY20161101194T patent/CY1118327T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1200352A1 (zh) | 吡唑衍生物用於治療慢性阻塞性肺病急性惡化的用途 | |
| IL285843A (en) | Ibrutinib for use in the treatment of graft-versus-host disease | |
| HK1211844A1 (zh) | 肺部疾病的治療 | |
| HK1198556A1 (zh) | 慢性阻塞性肺疾病患者的結果的預測 | |
| GB2512799B (en) | Transaction begin/end instructions | |
| LT2845593T (lt) | Piridino ir pirazino darinys, skirtas lėtinės obstrukcinės plaučių ligos gydymui | |
| EP2925382A4 (en) | AMBULATORY AND EXTRACORPORAL ASSISTANCE PUNGON | |
| PL2848254T3 (pl) | Pochodne pirazolu i ich zastosowanie w celach medycznych | |
| EP2913047A4 (en) | SPECIFIC THERAPEUTIC AGENT OF PULMONARY DISEASE | |
| GB201109524D0 (en) | Transaction authorisation | |
| HK1197297A1 (zh) | 肺癌中的 激酶 | |
| EP2840938A4 (en) | THERAPEUTIC CUSHION | |
| HK1206714A1 (zh) | 三唑甲酰胺衍生物 | |
| SG11201601807XA (en) | Methods for treating chronic obstructive pulmonary disease using benralizumab | |
| GB201116238D0 (en) | A process for assisting in the design of room layouts | |
| EP2826479A4 (en) | TREATMENT AGENT FOR CHRONIC-OBSTRUCTIVE LUNG DISEASE | |
| GB201217330D0 (en) | Therapeutic for treating inflammatory lung disorders | |
| EP2823818A4 (en) | USE OF RUPATADINE IN THE MANUFACTURE OF A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF OBSTRUCTIVE CHRONIC BRONCHOPNEUMOPATHY | |
| PL2861568T3 (pl) | Aminy trzeciorzędowe do zastosowania w leczeniu zaburzeń serca | |
| EP2817004A4 (en) | BOUVARDIN DERIVATIVES AND THEIR THERAPEUTIC USES | |
| PT2709584T (pt) | Utilização sensorial dos derivados de 6-ciclopentilideno-hexano | |
| IL233568A0 (en) | A method for treating obstructive lung disease | |
| TH1401005467B (th) | การใช้อนุพันธ์ไพราโซลในการรักษาการกำเริบแบบเฉียบพลันของโรคปอดอุดกั้นชนิดเรื้อรัง | |
| TH148366B (th) | การใช้อนุพันธ์ไพราโซลในการรักษาการกำเริบแบบเฉียบพลัน ของโรคปอดอุดกั้นชนิดเรื้อรัง | |
| ZA201505093B (en) | Use of 3-carboxy-n-ethyl-n,n-dimethylpropan-1-aminium or a pharmaceutically acceptable salt thereof in the treatment of atherosclerosis |